Escavo
  • Home
  • About
  • Services
  • Contact
  • Blog
Select Page

FDA approves angiotensin II formulation (Giapreza) for blood pressure maintenance in adults with refractory septic shock

by admin | Dec 22, 2017 | Recent Sepsis News

The US Food and Drug Administration (FDA) has approved an angiotensin II intravenous formulation (Giapreza, La Jolla Pharmaceutical Co) for the treatment of hypotension in adults with refractory distributive and septic shock not responsive to IV fluids and other...
Next Entries »

Recent Posts

  • testing in Spanish yeah cool
  • Hey Joe
  • News 3
  • News 2
  • News 1

Categories

  • Medical
  • Misc
  • Mobile technology
  • Product News
  • Recent Sepsis News
  • Regulatory
  • Uncategorized

Archives

  • March 2023
  • January 2023
  • October 2019
  • March 2019
  • September 2018
  • August 2018
  • May 2018
  • December 2017
  • October 2017
  • April 2017
  • September 2016
  • March 2016
  • February 2016
  • November 2015
  • March 2014
  • November 2013
  • September 2013
  • March 2013
  • January 2013
  • December 2012
  • September 2012
  • August 2012
  • July 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • September 2011
  • Facebook
  • Twitter
copyright 2018 Escavo Inc.